Watchlist Price Alert

Y-mAbs Therapeutics Inc. (YMAB)

NASDAQ: YMAB · Real-Time Price · USD

4.10

0.24 (6.22%)

At close: May 16, 2025, 3:59 PM

4.14

0.98%

After-hours: May 16, 2025, 04:28 PM EDT

Y-mAbs Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-29.67M	-21.43M	-95.57M	-55.27M	-119.34M	-81.03M	-43.27M	-19.16M	-17.06M
Depreciation & Amortization	535K	735K	839K	782K	396K	166K	29K	n/a	n/a
Stock-Based Compensation	14.56M	14.45M	25.6M	19.33M	16.14M	4.66M	1.97M	609K	258K
Other Working Capital	n/a	-4.59M	-3.44M	1.76M	2.59M	48K	-1.31M	360K	2.52M
Other Non-Cash Items	2.51M	-1.26M	3.58M	-62.01M	8.71M	43K	97K	-63K	2.28M
Deferred Income Tax	n/a	n/a	n/a	1.9M	-576K	n/a	n/a	n/a	n/a
Change in Working Capital	-3.65M	-19.73M	-10.37M	-7.28M	3.44M	2.67M	-47K	2.75M	3.35M
Operating Cash Flow	-15.71M	-27.23M	-75.92M	-102.56M	-91.23M	-73.5M	-41.23M	-15.87M	-11.17M
Capital Expenditures	n/a	n/a	n/a	-967K	-175K	-1.97M	-234K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	62.01M	-2.61M	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	61.04M	-2.79M	-1.97M	-234K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-366K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.31M	100K	84K	589K	2M	n/a	-1M	-258K	n/a
Financial Cash Flow	4.31M	100K	84K	108.31M	2M	134.7M	98.76M	89.59M	18.97M
Net Cash Flow	-11.4M	-27.13M	-75.8M	66.93M	-92.5M	59.27M	57.36M	73.61M	7.81M
Free Cash Flow	-15.71M	-27.23M	-75.92M	-103.52M	-91.41M	-75.46M	-41.46M	-15.87M	-11.17M